A clinical study to evaluate the efficacy and safety of docetaxel with ribavirin in patients with progressive prostate cancer who have previously recieved docetaxel
Not Applicable
- Conditions
- Prostate cancer
- Registration Number
- JPRN-UMIN000012521
- Lead Sponsor
- Department of Urology, Keio University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Uncontroled general complication. Diagnosis of or treatment for another systemic malignancy. etc
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method